David Mack is the inaugural recipient of a new multi-year award established by Larry and Eileen Tietze for mid-career level scientists. The grant will support efforts to engineer stem cell-derived neuromuscular junctions for the purpose of studying the onset of neuromuscular diseases and testing potential therapeutics.
Neuromuscular Disease Research Group
University of Washington, Institute for Stem Cell and Regenerative Medicine